Lucresca SE Form 4 COTY / SE Agnaten ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

JAB Beauty B.V.

(Last)

(First)

(Middle)

PIET HEINKADE 55

(Street)

AMSTERDAM

NL-1019 GM

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
COTY INC. [ COTY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/07/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock, par value $0.01 per share	09/07/2023		J		5,000,000⁽¹⁾	D	⁽¹⁾	448,853,684	D⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

1. Name and Address of Reporting Person^*

JAB Beauty B.V.

(Last)

(First)

(Middle)

PIET HEINKADE 55

(Street)

AMSTERDAM

NL-1019 GM

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

JAB Holdings B.V.

(Last)

(First)

(Middle)

PIET HEINKADE 55

(Street)

AMSTERDAM

NL-1019 GM

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Agnaten SE

(Last)

(First)

(Middle)

4, RUE JEAN MONNET

(Street)

LUXEMBOURG

L-2180

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Lucresca SE

(Last)

(First)

(Middle)

4, RUE JEAN MONNET

(Street)

LUXEMBOURG

L-2180

(City)

(State)

(Zip)

Explanation of Responses:

1. On September 7, 2023, JAB Beauty B.V. ("JAB Beauty") transferred 5,000,000 shares of Class A Common Stock of Coty Inc. (the "Company") to Sue Y. Nabi, the Company's Chief Executive Officer, pursuant to the Equity Transfer Agreement, dated as of July 2, 2020, by and among the Company, JAB Beauty and Ms. Nabi.

2. The Shares described in this report are held by JAB Beauty B.V., a direct or indirect subsidiary of each other Reporting Person herein. As such, each other Reporting Person herein may be deemed to beneficially own such Shares held by JAB Beauty B.V. Each of the Reporting Persons disclaims any beneficial ownership of such Shares, except to the extent of its pecuniary interests therein.

	/s/ Luuk Hoogeveen, Managing Director of JAB Beauty B.V.	09/11/2023
	/s/ Frank Engelen, Managing Director of JAB Beauty B.V.	09/11/2023
	/s/ Luuk Hoogeveen, Managing Director of JAB Holdings B.V.	09/11/2023
	/s/ Frank Engelen, Managing Director of JAB Holdings B.V.	09/11/2023
	/s/ Joachim Creus, Authorized Representative of Agnaten SE	09/11/2023
	/s/ Joachim Creus, Authorized Representative of Lucresca SE	09/11/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Lucresca SE Form 4COTY / SE Agnaten ownership change